State Regulations

In accordance with Colorado and Connecticut state laws, Melinta is disclosing this price information in the form required.

Colorado Prescriber Wholesale Acquisition Cost Information

In accordance with Colorado Revised Statutes Section 12-280-308, Melinta is disclosing the required pricing information for its
marketed products.
Please choose a product from the list below:

Baxdela® (delafloxacin) Colorado Prescriber Information

Kimyrsa® (oritavancin) Colorado Prescriber Information

Minocin® (Minocycline) Colorado Prescriber Information

Orbactiv® (oritavancin) Colorado Prescriber Information

Rezzayo® (rezafungin for injection) Colorado Prescriber Information

Vabomere® (meropenem and vaborbactam) Colorado Prescriber Information

Connecticut Prescriber & Pharmacist Wholesale Acquisition Cost Information

In accordance with Connecticut Public Act No. 23-171, Melinta is disclosing the required pricing information for its marketed products.
Please choose a product from the list below:

Baxdela® (delafloxacin) Connecticut Prescriber Information

Kimyrsa® (oritavancin) Connecticut Prescriber Information

Minocin® (Minocycline) Connecticut Prescriber Information

Orbactiv® (oritavancin) Connecticut Prescriber Information

Rezzayo® (rezafungin for injection) Connecticut Prescriber Information

Vabomere® (meropenem and vaborbactam) Connecticut Prescriber Information

Additional Information

The pricing information disclosed on this page may not represent the actual price a customer will pay to acquire the product. The actual transaction price may include discounts, rebates or reductions in price not represented here. A patient’s cost will depend on their insurance coverage. Patients should contact their health insurer or pharmacy to learn the exact cost of their prescription.

Pricing information provided on this page does not imply safety or efficacy information and should not be used to make safety or efficacy comparisons. The listing of a generic product does not imply that the product is interchangeable with the Melinta marketed product. The intent of this webpage is solely to provide pricing information as required by state law. Please refer to each product’s U.S. Food and Drug Administration (FDA)-approved prescribing information or your healthcare provider for further information. To access FDA-approved prescribing information for Melinta-marketed products, visit https://melinta.com/our-products.